Targeting STAT3 and STAT5 in Cancer
Every minute, 34 new patients are diagnosed with cancer globally. Although over the past 50 years treatments have improved and survival rates have increased dramatically for several types of cancers, many remain incurable. Several aggressive types of blood and solid cancers form when mutations occur...
Saved in:
HerausgeberIn: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (578 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting PI3K/MTOR signaling in cancer / / topic editor, Alexandre Arcaro.
by: Alexandre Arcaro
Published: (2014) -
Therapeutic Targeting of Cancer Stem-Like Cells (CSC) – The Current State of the Art
by: Corbet, Cyril
Published: (2020) -
Brain cancer, tumor targeting, and cervical cancer / Elena K. Salvatti, editor.
Published: (c2011.) -
Targeting Myeloid Cells to Fight Cancer
by: Hollmén, Maija
Published: (2020) -
Targeting protein kinases for cancer therapy / David J. Matthews, Mary E. Gerritsen.
by: Matthews, David J.
Published: (c2010.)